JBS N.V. (JBS): A Bull Case Theory

Tony Campbell/Shutterstock.com

JBS S.A. is simply a planetary macromolecule powerhouse with unmatched standard crossed beef, pork, poultry, and diversified products, including plant-based proteins, leather, and biodiesel. Its operations span 250+ facilities and 180+ countries, giving it important bargaining power, organisation advantages, and integration from livestock to last products.

Strong secular request for protein, driven by colonisation maturation and rising incomes successful emerging markets, underpins semipermanent growth, and geographic expansion—particularly successful Europe done acquisitions—is poised to seizure further marketplace share. However, the concern remains exposed to commodity cycles, livestock proviso constraints, commercialized barriers, tariffs, and macro volatility, which compress margins and marque readying challenging.

Recent results bespeak this mix: Q3 2025 nett income roseate ~13% to $22.6 billion, but nett and EBITDA declined owed to choky U.S. beef supplies and rising input costs. Competitive spot derives from scale, integration, and diversification, but the moat is moderate, arsenic rivals similar Tyson Foods, Marfrig, and BRF, alongside changing user preferences toward alternate proteins, tin unit marketplace share. Management is opportunistic, pursuing ~$2 cardinal yearly CapEx for installation modernization and higher-margin segments, enabled by a dual NYSE listing for cheaper capital, though leverage (~2.4x) and cyclical hazard necessitate cautious discipline.

Key risks see commodity cycles, illness outbreaks, ESG/legal pressures, and commercialized disruptions, which could materially impact profitability. Upside exists done European acquisitions, operational improvements, and maturation successful prepared foods oregon plant-based proteins, portion downside remains tied to cyclicality and regulatory pressures. Valuation is attractive, with a guardant P/E of ~9.1 and beardown ROE (~23.7%), though net volatility warrants caution. Overall, JBS offers a balanced risk/reward, with semipermanent worth seizure contingent connected execution and macro stability.

Previously, we covered a bullish thesis on McCormick & Company, Incorporated (MKC) by Investing Lawyer successful February 2025, which highlighted the company’s antiaircraft positioning successful the spice and flavoring industry, accordant dividend growth, and structural enactment astir cardinal terms levels for semipermanent investors. MKC’s banal terms has depreciated by approximately 16.10% since our coverage. Danny Green shares a akin presumption but emphasizes JBS’s planetary scale, macromolecule marketplace integration, and maturation done geographic enlargement and operational improvements.